Technology-Assisted Collaborative Care Program for People with Diabetes and/or High Blood Pressure Attending Primary Health Care: A Feasibility Study

The comorbidity of depression with physical chronic diseases is usually not considered in clinical guidelines. This study evaluated the feasibility of a technology-assisted collaborative care (TCC) program for depression in people with diabetes and/or high blood pressure (DM/HBP) attending a primary...

Full description

Saved in:
Bibliographic Details
Published in:International journal of environmental research and public health 2021-11, Vol.18 (22), p.12000
Main Authors: Martínez, Pablo, Guajardo, Viviana, Gómez, Víctor E., Brandt, Sebastián, Szabo, Wilsa, Soto-Brandt, Gonzalo, Farhang, Maryam, Baeza, Paulina, Campos, Solange, Herrera, Pablo, Rojas, Graciela
Format: Article
Language:English
Subjects:
Blood pressure
Cellular telephones
Chronic illnesses
Collaboration
Comorbidity
Diabetes
Diabetes mellitus
Digitization
Disease prevention
Family medical history
Feasibility studies
Health care
Health services
Hypertension
Intervention
Mental depression
Mental health
Patients
Problem solving
Psychologists
Quality of life
Questionnaires
Signs and symptoms
Technology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The comorbidity of depression with physical chronic diseases is usually not considered in clinical guidelines. This study evaluated the feasibility of a technology-assisted collaborative care (TCC) program for depression in people with diabetes and/or high blood pressure (DM/HBP) attending a primary health care (PHC) facility in Santiago, Chile. Twenty people diagnosed with DM/HBP having a Patient Health Questionnaire-9 score ≥ 15 points were recruited. The TCC program consisted of a face-to-face, computer-assisted psychosocial intervention (CPI, five biweekly sessions), telephone monitoring (TM), and a mobile phone application for behavioral activation (CONEMO). Assessments of depressive symptoms and other health-related outcomes were made. Thirteen patients completed the CAPI, 12 received TM, and none tried CONEMO. The TCC program was potentially efficacious in treating depression, with two-thirds of participants achieving response to depression treatment 12 weeks after baseline. Decreases were observed in depressive symptoms and healthcare visits and increases in mental health-related quality of life and adherence to treatment. Patients perceived the CPI as acceptable. The TCC program was partially feasible and potentially efficacious for managing depression in people with DM/HBP. These data are valuable inputs for a future randomized clinical trial.
ISSN:1660-4601
1661-7827
1660-4601
DOI:10.3390/ijerph182212000